BHS Linz: Interne I: Internistische Onkologie, Hämatologie und Gastroenterologie
About BHS Linz: Interne I: Internistische Onkologie, Hämatologie und Gastroenterologie
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Arbeitsgemeinschaft medikamentoese Tumortherapie
3
Hoffmann-La Roche
3
Clinical Trials at BHS Linz: Interne I: Internistische Onkologie, Hämatologie und Gastroenterologie
During the past decade, BHS Linz: Interne I: Internistische Onkologie, Hämatologie und Gastroenterologie conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Ixazomib (MLN9708) in Combination With Carboplatin in Pretreated Women With Advanced Triple Negative Breast Cancer
2016-11-21
2020-08-15
Terminated
31
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
2018-08-02
2025-08-24
Active, not recruiting
2,300
Denosumab for High Risk SMM and SLiM CRAB Positive, Early Myeloma Patients
2019-09-30
2024-07-01
Active, not recruiting
8
A Study Of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer.
2019-11-25
2023-02-28
Completed
242
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
2021-05-04
2034-10-26
Recruiting
1,700
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "BHS Linz: Interne I: Internistische Onkologie, Hämatologie und Gastroenterologie"
#1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Assign Data Management and Biostatistics GmbH" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at BHS Linz: Interne I: Internistische Onkologie, Hämatologie und Gastroenterologie
According to Clinical.Site data, the most researched conditions in "BHS Linz: Interne I: Internistische Onkologie, Hämatologie und Gastroenterologie" are
"Triple-Negative Breast Cancer" (2 trials), "Breast Cancer" (1 trials), "Cancer Cervix" (1 trials), "Cancer Colorectal" (1 trials) and "Cancer Head Neck" (1 trials). Many other conditions were trialed in "BHS Linz: Interne I: Internistische Onkologie, Hämatologie und Gastroenterologie" in a lesser frequency.
Clinical Trials Intervention Types at BHS Linz: Interne I: Internistische Onkologie, Hämatologie und Gastroenterologie
Most popular intervention types in "BHS Linz: Interne I: Internistische Onkologie, Hämatologie und Gastroenterologie" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (3 trials), "Paclitaxel" (2 trials), "Carboplatin" (1 trials), "Cyclophosphamide" (1 trials) and "Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA]" (1 trials). Other intervention names were less common.
Clinical Trials Genders at BHS Linz: Interne I: Internistische Onkologie, Hämatologie und Gastroenterologie
The vast majority of trials in "BHS Linz: Interne I: Internistische Onkologie, Hämatologie und Gastroenterologie" are
5 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at BHS Linz: Interne I: Internistische Onkologie, Hämatologie und Gastroenterologie
Currently, there are NaN active trials in "BHS Linz: Interne I: Internistische Onkologie, Hämatologie und Gastroenterologie".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in BHS Linz: Interne I: Internistische Onkologie, Hämatologie und Gastroenterologie,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in BHS Linz: Interne I: Internistische Onkologie, Hämatologie und Gastroenterologie, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".